First Citizens BancShares
FCNCA
$2111.89
-0.41%
First Citizens BancShares Inc. is a US regional bank holding company headquartered in Raleigh, North Carolina, with approximately $236 billion in total assets as of March 31, 2026, operating across retail, commercial, wealth management, and railcar leasing segments. The bank is best known for its opportunistic FDIC-assisted acquisitions, most notably Silicon Valley Bridge Bank in 2023, which doubled its asset base and transformed it into one of the largest regional banks in the country, with dominant deposit franchises in North Carolina, South Carolina, and California. The current investor narrative centers on the durability of net interest income after the SVB acquisition windfall, the trajectory of credit quality as commercial real estate exposures are digested, and the bank's aggressive capital return program — management repurchased roughly $900 million of stock in Q4 2025 alone. With the stock trading at a modest premium to book value and analysts largely neutral, the debate is whether First Citizens can sustain its historically strong returns as acquisition-related accretion fades and loan growth normalizes.…
FCNCA
First Citizens BancShares
$2111.89
Investment Opinion: Should I buy FCNCA Today?
The synthesized recommendation is Hold, with a neutral stance reflecting the bank's solid franchise but lack of near-term catalysts. The analyst consensus rating of 2.69 (hold) and average target price of $2,335.54 imply 10.6% upside, but this is not compelling enough to justify a Buy given the earnings decline and revenue stagnation. The core thesis is that FCNCA is a well-capitalized regional bank trading at a modest discount to book value, but its growth prospects are limited until net interest income stabilizes and credit costs normalize.
Supporting evidence for the Hold rating includes the 1.19x price-to-book ratio, which is below the 1.5–2.0x typical for premium regional banks, and the 12.95x trailing PE, which is undemanding. However, revenue growth is negative at -0.92% year-over-year, and net income declined 17.1% in Q4 2025. The bank's ROE of 9.92% and ROA of 1.01% are below peer averages, and the 0.61% dividend yield with a 7.3% payout ratio offers minimal income. The $3.027 billion buyback in 2025 has reduced share count by 11.3% year-over-year, cushioning EPS, but this pace may not be sustainable.
The biggest risks that could invalidate the thesis are a deterioration in credit quality, particularly in commercial real estate, and a continued decline in net interest margin. The Hold rating would upgrade to Buy if the stock pulls back to 1.0x book (around $1,770) or if revenue growth turns positive for two consecutive quarters. It would downgrade to Sell if credit costs spike, pushing ROE below 8% or if the buyback is significantly reduced. Relative to its history and peers, FCNCA appears fairly valued to slightly undervalued, but the lack of growth catalysts justifies a neutral stance.
Sign up to view all
FCNCA 12-Month Price Forecast
FCNCA presents a balanced risk/reward profile with limited near-term catalysts. The stock is cheap at 1.19x book and 12.95x earnings, but revenue stagnation and declining earnings offset the valuation appeal. The aggressive buyback is supportive but may not be sustainable if earnings continue to decline. Analyst sentiment is neutral, with a tight target range and no recent upgrades. I would upgrade to bullish if revenue growth turns positive and net interest margin expands, or downgrade to bearish if credit costs rise significantly or the buyback is curtailed.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on First Citizens BancShares's 12-month outlook, with a consensus price target around $2335.54 and implied upside of +10.6% versus the current price.
Average Target
$2335.54
0 analysts
Implied Upside
+10.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$2100 - $2525
Analyst target range
Coverage is moderate with 13 analysts, and the consensus is distinctly lukewarm: the recommendation is "hold" with a mean rating of 2.69 (where 1 is strong buy and 5 is strong sell), and the average target price of $2,335.54 implies roughly 10.6% upside from the current $2,111.89. The distribution skews neutral — recent actions from Piper Sandler (Neutral), Truist (Hold), Citigroup (Neutral), and Barclays (Equal Weight) dominate, with only TD Cowen (Buy), UBS (Buy), and JP Morgan (Overweight) on the bullish side. This is a consensus that respects the franchise but sees limited near-term catalysts, consistent with the stock's year-to-date underperformance.
The target range of $2,100 to $2,525 is relatively tight — the low target sits essentially at the current price, implying zero downside protection from the most bearish analyst, while the high target of $2,525 assumes roughly 19.6% upside and would require either multiple expansion back toward 1.4x book or a meaningful earnings recovery. Notably, no analyst has a target below the current price, which suggests the sell-side views the recent pullback as a buying opportunity rather than the start of a deeper decline. However, the absence of any recent upgrades — the institutional ratings log shows only reiterations since October 2025 — signals that analysts are in wait-and-see mode, likely awaiting clarity on credit quality and net interest margin trends before adjusting estimates. The consensus EPS estimate of $217.14 for the forward year, against a current quarterly run-rate of roughly $45.81, implies analysts expect earnings to be roughly flat to slightly higher, reinforcing the "hold" stance.
Bulls vs Bears: FCNCA Investment Factors
The bear case currently has stronger evidence, primarily because revenue has flatlined for eight consecutive quarters and earnings are declining, with Q4 2025 net income down 17.1% year-over-year. The bull case rests on valuation support at 1.19x book and the potential for buybacks to cushion per-share metrics, but these are defensive rather than growth-oriented arguments. The single most important tension is whether the bank can stabilize net interest income and credit costs as the SVB acquisition accretion fades — if it can, the stock is undervalued; if not, the 1.19x book multiple could compress further. Analyst consensus is neutral with a 2.69 mean rating and a tight target range of $2,100–$2,525, reflecting uncertainty about the bank's organic growth trajectory. Given the lack of near-term catalysts and relative underperformance, the risk/reward is balanced but tilted slightly negative until revenue growth inflects.
Bullish
- Deep Value at 1.19x Book: FCNCA trades at just 1.19x price-to-book and 12.95x trailing earnings, well below the 1.5–2.0x book multiples typically commanded by premium regional banks. This discount provides a margin of safety and limits downside if credit conditions remain stable.
- Aggressive Buyback Shrinking Float: Management repurchased $900 million of stock in Q4 2025 alone and $3.027 billion across the full year, reducing diluted shares from 13.93 million to 12.36 million year-over-year. This buyback is cushioning EPS declines and signals confidence in intrinsic value.
- Analyst Targets Imply Upside: The average analyst target of $2,335.54 implies 10.6% upside from the current $2,111.89, and the high target of $2,525 implies 19.6% upside. Notably, no analyst has a target below the current price, suggesting the sell-side views the recent pullback as a buying opportunity.
- Low Beta Defensive Profile: With a beta of 0.596, FCNCA is roughly 40% less volatile than the broader market, making it an attractive defensive holding in uncertain macro environments. This low beta also allows for larger position sizing tolerance without excessive portfolio risk.
Bearish
- Revenue Growth Has Flatlined: Q4 2025 revenue of $3.655 billion declined 0.92% year-over-year, and the quarterly revenue band of roughly $3.5–3.7 billion has held for eight straight quarters. The SVB acquisition boost has been fully absorbed, and organic growth is essentially absent.
- Earnings Decline and Tax Headwind: Q4 2025 net income fell 17.1% to $580 million from $700 million a year earlier, and diluted EPS dropped to $45.81 from $49.21. The effective tax rate jumped to 28.48% from just 4.89% in Q4 2024, which flattered the prior-year comparison and will continue to pressure earnings.
- Weak Returns Below Peer Standards: ROE of 9.92% and ROA of 1.01% are below what a high-quality regional bank typically delivers, indicating the bank is not generating exceptional returns on its expanded asset base. This raises questions about the sustainability of its premium valuation relative to book value.
- Relative Underperformance and Weak Momentum: FCNCA has lagged the S&P 500 by 3.62 percentage points over 12 months and a striking 13.87 points year-to-date, with the stock down 2.17% YTD versus the market's 11.7% gain. The recent lower-high sequence from the August peak suggests persistent selling pressure.
FCNCA Technical Analysis
First Citizens is in a broad, choppy uptrend that has stalled over the past year, with the shares up 11.39% over 12 months versus a 15.01% gain for the S&P 500, a relative underperformance of 3.62 percentage points. At $2,111.89, the stock sits at roughly 72.6% of its 52-week range (52-week low of $1,623.76 and high of $2,296.30), positioning it in the upper-middle of its band — not extended enough to signal euphoria, but far enough off the lows to suggest the easy recovery trade has already been made. The 19.86% maximum drawdown over the period confirms this is a stock that has experienced meaningful pullbacks even within its uptrend, so positioning near the upper third of the range should be treated as momentum with vulnerability rather than a clean breakout setup.
Short-term momentum has turned soft and is diverging from the longer-term trend: the stock is down 2.71% over the past month and down 2.17% year-to-date, even though it is up 1.94% over three months and 15.89% over six months. This deceleration is corroborated by relative strength figures — FCNCA has lagged SPY by 1.75 points over one month and a striking 13.87 points year-to-date, meaning the market's 2026 advance has largely bypassed this name. The recent price action shows a clear lower-high sequence from the August 14 peak of $2,291.33 down to $2,111.89, a roughly 7.8% retreat, with the last two sessions printing $2,120.58 and $2,111.89 on modest volume of about 142,000 shares, suggesting selling pressure is persistent but not panicked.
Key technical levels are well defined: immediate support sits at the September 16 close of $2,099.57 and then the psychological $2,000 area, while the 52-week low of $1,623.76 represents the deeper structural floor. Resistance is anchored at the 52-week high of $2,296.30, and a decisive breakout above that level would signal renewed institutional accumulation and likely open the door to the analyst high target of $2,525. Conversely, a breakdown below $2,000 would break the six-month uptrend structure and put the $1,900–1,950 zone in play. With a beta of just 0.596, FCNCA is roughly 40% less volatile than the broader market, which argues for larger position sizing tolerance but also means the stock will likely lag in sharp risk-on rallies — a critical consideration given its year-to-date relative weakness.
Beta
0.60
0.60x market volatility
Max Drawdown
-19.9%
Largest decline past year
52-Week Range
$1624-$2296
Price range past year
Annual Return
+11.4%
Cumulative gain past year
| Period | FCNCA Return | S&P 500 |
|---|---|---|
| 1m | -2.7% | -0.5% |
| 3m | +1.9% | +2.3% |
| 6m | +15.9% | +16.6% |
| 1y | +11.4% | +14.8% |
| ytd | -2.2% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FCNCA Fundamental Analysis
Revenue has flatlined rather than grown: Q4 2025 revenue of $3.655 billion declined 0.92% year-over-year versus Q4 2024's $3.689 billion, and the sequential trend is similarly uninspiring — $3.525 billion in Q1 2025, $3.623 billion in Q2, $3.694 billion in Q3, and $3.655 billion in Q4. The quarterly revenue band of roughly $3.5–3.7 billion has held for eight straight quarters, indicating the SVB acquisition's balance-sheet boost has been fully absorbed and organic growth is essentially absent. Within the fee mix, deposit fees and service charges ($63 million) and asset management ($61 million) are the largest contributors, but these are small relative to spread income, meaning the investment case hinges almost entirely on net interest margin and credit costs rather than diversified fee growth.
Profitability remains solid but is compressing at the margin: Q4 2025 net income was $580 million on a 15.87% net margin, down from $700 million and an 18.98% net margin in Q4 2024, a 17.1% earnings decline. Gross margin has been remarkably stable in the 60.6–62.3% range across all four quarters of 2025, and the operating margin of 22.19% in Q4 2025 was actually an improvement from 18.47% in Q1 2025, but the effective tax rate jumped to 28.48% in Q4 2025 from just 4.89% in Q4 2024, which flattered the prior-year comparison. Diluted EPS fell to $45.81 in Q4 2025 from $49.21 a year earlier, and the shrinking share count (12.36 million diluted shares in Q4 2025 versus 13.93 million a year prior) is doing meaningful work in cushioning per-share declines — without the buyback, EPS deterioration would be materially worse.
Balance sheet and cash flow metrics are adequate but not exceptional for a bank of this size: debt-to-equity stands at 1.62x, ROE is 9.92%, and ROA is a thin 1.01%, both below what a high-quality regional bank typically delivers. Free cash flow on a trailing-twelve-month basis is $2.071 billion, but quarterly FCF has been volatile — $720 million in Q4 2025, $1.008 billion in Q3, $518 million in Q2, and negative $175 million in Q1 — and the current ratio of 1.03 is barely above parity. The bank returned substantial capital in 2025, repurchasing $900 million of stock in Q4 alone and $3.027 billion across the year, funded partly by $2.695 billion of debt repayment and $4.752 billion of net financing outflows, which raises the question of how long this pace of buybacks can be sustained if earnings continue to drift lower.
Quarterly Revenue
$3.7B
2025-12
Revenue YoY Growth
-0.9%
YoY Comparison
Gross Margin
62.1%
Latest Quarter
Free Cash Flow
$2.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FCNCA Overvalued?
Because First Citizens is solidly profitable — Q4 2025 net income of $580 million and trailing EPS of $45.81 per quarter — the PE ratio is the appropriate primary metric, and it paints a value picture: the trailing PE is 12.95x while the forward PE is 10.69x, a 17.5% compression that implies the market expects earnings to grow into the current price. That forward discount is notable given the company's recent earnings decline, suggesting either analyst estimates are too optimistic or the market is pricing in a normalization of credit costs and tax rates. The price-to-book ratio of 1.19x is the other key anchor for a bank, and at just 19% above book value, FCNCA is not being priced for heroic execution.
Relative to the broader regional banking sector, FCNCA screens as a modest value: the 12.95x trailing PE and 1.19x price-to-book are below the multiples typically commanded by premium regional banks (which often trade at 1.5–2.0x book), while the 1.83x price-to-sales ratio and 9.08x price-to-cash-flow ratio are undemanding. The PEG ratio of -1.04 is not meaningful given negative earnings growth, and the EV/EBITDA of 12.34x is elevated for a bank but reflects the holding company's consolidated structure. The 0.61% dividend yield and 7.3% payout ratio are exceptionally low, signaling that management prioritizes buybacks over income — a rational choice at 1.19x book but one that limits the stock's appeal to yield-oriented investors.
Historically, FCNCA's valuation has been volatile: the PE ranged from a distorted 0.37x in Q1 2023 (SVB bargain-purchase accounting) to 16.5x in Q4 2021, and the price-to-book has ranged from 0.74x in Q1 2023 to 1.90x in Q1 2021. At 1.19x book and 12.95x earnings, the stock sits in the middle of its multi-year band — cheaper than the 2021 premium but richer than the 2023 distressed levels. The current 1.19x book is also above the 1.05x–1.16x readings seen through most of 2025, implying the market has already re-rated the shares modestly higher even as earnings declined, which leaves limited margin of safety if credit conditions deteriorate.
PE
12.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 7x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
First Citizens faces significant financial and operational risks stemming from its flatlined revenue and declining profitability. Revenue has been stuck in a $3.5–3.7 billion quarterly band for eight straight quarters, with Q4 2025 declining 0.92% year-over-year, indicating no organic growth engine. Net income fell 17.1% to $580 million in Q4 2025, and the effective tax rate jumped to 28.48% from 4.89% a year earlier, which will continue to pressure earnings. The bank's ROE of 9.92% and ROA of 1.01% are below peer standards, and the aggressive $3.027 billion buyback in 2025 was funded partly by debt repayment and financing outflows, raising sustainability concerns if earnings continue to decline.
Market and competitive risks are elevated due to the bank's premium valuation relative to its weak growth profile and its significant exposure to commercial real estate. At 1.19x book and 12.95x trailing earnings, FCNCA trades above the 1.05–1.16x book range seen through most of 2025, leaving limited margin of safety if credit conditions deteriorate. The stock's beta of 0.596 means it will likely lag in sharp risk-on rallies, as evidenced by its 13.87 percentage point year-to-date underperformance versus the S&P 500. Additionally, the bank's concentration in North Carolina, South Carolina, and California exposes it to regional economic downturns, and its SVB acquisition has left it with a large portfolio of commercial loans that could face credit quality issues in a recession.
A worst-case scenario would involve a deterioration in credit quality, particularly in commercial real estate, leading to higher loan loss provisions and a compression of net interest margin. This could cause earnings to decline further, potentially pushing the stock down to its 52-week low of $1,623.76, which represents a 23.1% decline from the current price of $2,111.89. If the bank's buyback program is curtailed due to capital constraints, the EPS cushion would disappear, accelerating the downside. In this adverse scenario, investors could lose approximately 23% from the current price, with the analyst low target of $2,100 offering essentially no downside protection.
FAQ
The key risks include financial risks such as declining earnings (Q4 2025 net income down 17.1% YoY) and weak returns (ROE 9.92%, ROA 1.01%). Competitive risks include exposure to commercial real estate and regional economic downturns in North Carolina, South Carolina, and California. Macro risks include a low beta of 0.596, which may cause underperformance in risk-on markets, and potential regulatory capital requirements limiting buybacks. Company-specific risks include the sustainability of the $3.027 billion buyback program and the impact of a higher effective tax rate (28.48% in Q4 2025).
The 12-month forecast has a base case (55% probability) targeting $2,100–$2,335, a bull case (25% probability) targeting $2,335–$2,525, and a bear case (20% probability) targeting $1,623–$2,100. The base case assumes revenue remains range-bound and earnings stabilize, while the bull case requires net interest margin expansion and loan growth. The bear case is triggered by a commercial real estate downturn or recession. The most likely scenario is the base case, with the stock drifting toward the average analyst target of $2,335.
FCNCA appears fairly valued to slightly undervalued, trading at 1.19x book and 12.95x trailing earnings, below the 1.5–2.0x book multiples of premium regional banks. The forward PE of 10.69x implies a 17.5% earnings growth expectation, which may be optimistic given the recent earnings decline. The stock is in the middle of its historical valuation range, cheaper than the 2021 premium but richer than the 2023 distressed levels. The market is pricing in modest growth and stable credit conditions, leaving limited margin of safety if conditions deteriorate.
FCNCA is a hold-rated stock with a balanced risk/reward profile. The average analyst target of $2,335.54 implies 10.6% upside, but the stock faces revenue stagnation and a 17.1% earnings decline in Q4 2025. The 1.19x price-to-book valuation provides some downside protection, but the lack of growth catalysts limits upside potential. It could be a good buy for value investors with a long-term horizon who are comfortable with a low-beta, defensive holding, but growth-oriented investors may find better opportunities elsewhere.
FCNCA is more suitable for long-term investment due to its low beta (0.596), stable dividend (0.61% yield), and value-oriented valuation (1.19x book). Short-term trading is less attractive given the stock's recent relative underperformance (-13.87% YTD vs. S&P 500) and lack of near-term catalysts. The bank's earnings visibility is moderate, with revenue flat for eight quarters, suggesting a minimum holding period of 2–3 years to allow for potential net interest margin recovery and credit normalization. Income investors may appreciate the consistent buyback, but the low dividend yield limits appeal for income-focused portfolios.